Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chest Pain | 28 | 2022 | 205 | 10.930 |
Why?
|
| Acute Coronary Syndrome | 20 | 2022 | 194 | 6.970 |
Why?
|
| Emergency Service, Hospital | 30 | 2021 | 467 | 6.170 |
Why?
|
| Myocardial Infarction | 17 | 2021 | 473 | 5.140 |
Why?
|
| Troponin | 16 | 2020 | 106 | 3.790 |
Why?
|
| Patient Discharge | 7 | 2019 | 186 | 2.170 |
Why?
|
| Decision Support Techniques | 5 | 2020 | 128 | 2.140 |
Why?
|
| Critical Pathways | 6 | 2018 | 49 | 2.040 |
Why?
|
| Hospitalization | 4 | 2021 | 468 | 1.880 |
Why?
|
| Electrocardiography | 14 | 2020 | 604 | 1.750 |
Why?
|
| Risk Assessment | 16 | 2021 | 1427 | 1.740 |
Why?
|
| Emergency Medical Services | 5 | 2022 | 177 | 1.510 |
Why?
|
| Humans | 58 | 2022 | 32082 | 1.410 |
Why?
|
| Adult | 30 | 2022 | 9375 | 1.410 |
Why?
|
| Troponin T | 2 | 2021 | 80 | 1.300 |
Why?
|
| Middle Aged | 33 | 2022 | 11834 | 1.290 |
Why?
|
| Male | 40 | 2022 | 19202 | 1.200 |
Why?
|
| Decision Making | 5 | 2016 | 194 | 1.190 |
Why?
|
| Prospective Studies | 16 | 2022 | 2282 | 1.160 |
Why?
|
| Female | 38 | 2022 | 19999 | 1.160 |
Why?
|
| Emergency Medicine | 5 | 2014 | 115 | 1.140 |
Why?
|
| Health Personnel | 2 | 2018 | 121 | 1.140 |
Why?
|
| Catheterization, Peripheral | 3 | 2013 | 29 | 1.130 |
Why?
|
| Ultrasonography, Interventional | 3 | 2013 | 53 | 1.110 |
Why?
|
| Aged | 27 | 2021 | 10308 | 1.100 |
Why?
|
| Cardiology Service, Hospital | 3 | 2015 | 23 | 1.040 |
Why?
|
| Heart | 4 | 2022 | 176 | 0.950 |
Why?
|
| Acute Disease | 6 | 2021 | 252 | 0.930 |
Why?
|
| Internship and Residency | 4 | 2014 | 311 | 0.890 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 1128 | 0.890 |
Why?
|
| Coronary Angiography | 5 | 2018 | 153 | 0.860 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 873 | 0.840 |
Why?
|
| Cohort Studies | 8 | 2021 | 1816 | 0.810 |
Why?
|
| Clinical Competence | 4 | 2012 | 331 | 0.780 |
Why?
|
| Exercise Test | 7 | 2019 | 225 | 0.770 |
Why?
|
| Educational Measurement | 2 | 2012 | 122 | 0.740 |
Why?
|
| Risk Factors | 11 | 2021 | 3880 | 0.730 |
Why?
|
| North Carolina | 9 | 2020 | 1538 | 0.720 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 217 | 0.710 |
Why?
|
| Myocardial Revascularization | 3 | 2018 | 41 | 0.700 |
Why?
|
| Ambulances | 1 | 2020 | 13 | 0.700 |
Why?
|
| United States | 11 | 2021 | 3975 | 0.700 |
Why?
|
| Transportation of Patients | 1 | 2020 | 25 | 0.690 |
Why?
|
| Mortality | 1 | 2020 | 125 | 0.680 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 881 | 0.650 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 407 | 0.640 |
Why?
|
| Time Factors | 10 | 2020 | 2145 | 0.640 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 22 | 0.640 |
Why?
|
| Clinical Protocols | 2 | 2016 | 97 | 0.620 |
Why?
|
| Chemokine CCL2 | 1 | 2018 | 48 | 0.610 |
Why?
|
| Point-of-Care Systems | 3 | 2020 | 44 | 0.600 |
Why?
|
| Ethnic Groups | 1 | 2020 | 476 | 0.600 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 28 | 0.600 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 58 | 0.600 |
Why?
|
| Public Health | 1 | 2018 | 89 | 0.600 |
Why?
|
| Qualitative Research | 1 | 2018 | 175 | 0.600 |
Why?
|
| Education, Distance | 1 | 2018 | 19 | 0.600 |
Why?
|
| Certification | 1 | 2018 | 27 | 0.600 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 50 | 0.580 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.570 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 160 | 0.560 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 2263 | 0.550 |
Why?
|
| Length of Stay | 4 | 2015 | 312 | 0.550 |
Why?
|
| Odds Ratio | 4 | 2020 | 472 | 0.540 |
Why?
|
| Students, Medical | 1 | 2018 | 130 | 0.530 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 94 | 0.510 |
Why?
|
| Death | 1 | 2015 | 49 | 0.510 |
Why?
|
| Health Care Costs | 1 | 2016 | 118 | 0.510 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 581 | 0.490 |
Why?
|
| Robotics | 1 | 2016 | 124 | 0.490 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 401 | 0.470 |
Why?
|
| Observation | 2 | 2013 | 25 | 0.470 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 516 | 0.460 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 765 | 0.450 |
Why?
|
| Emergency Treatment | 1 | 2013 | 42 | 0.430 |
Why?
|
| Crowding | 2 | 2014 | 8 | 0.420 |
Why?
|
| Retrospective Studies | 8 | 2021 | 3505 | 0.410 |
Why?
|
| Logistic Models | 4 | 2020 | 783 | 0.400 |
Why?
|
| Coronary Vessels | 1 | 2013 | 165 | 0.390 |
Why?
|
| Education, Medical | 1 | 2012 | 69 | 0.390 |
Why?
|
| Cardiac Electrophysiology | 1 | 2011 | 3 | 0.380 |
Why?
|
| Ultrasonography | 2 | 2011 | 378 | 0.380 |
Why?
|
| Teaching | 1 | 2011 | 63 | 0.360 |
Why?
|
| Electrolytes | 1 | 2010 | 11 | 0.360 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2010 | 5 | 0.360 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2010 | 11 | 0.360 |
Why?
|
| Curriculum | 1 | 2012 | 213 | 0.350 |
Why?
|
| Prognosis | 6 | 2020 | 1496 | 0.350 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 127 | 0.350 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2011 | 84 | 0.350 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 28 | 0.330 |
Why?
|
| Incidence | 4 | 2018 | 1199 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 917 | 0.320 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 88 | 0.320 |
Why?
|
| Seat Belts | 1 | 2008 | 17 | 0.310 |
Why?
|
| Algorithms | 4 | 2019 | 496 | 0.310 |
Why?
|
| Triage | 2 | 2021 | 71 | 0.300 |
Why?
|
| Balanitis | 1 | 2007 | 3 | 0.300 |
Why?
|
| Penile Diseases | 1 | 2007 | 3 | 0.300 |
Why?
|
| Soft Tissue Infections | 1 | 2007 | 7 | 0.300 |
Why?
|
| Abscess | 1 | 2007 | 26 | 0.290 |
Why?
|
| Hispanic Americans | 2 | 2020 | 940 | 0.280 |
Why?
|
| Internet | 1 | 2008 | 197 | 0.270 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1542 | 0.250 |
Why?
|
| Survival Rate | 2 | 2018 | 876 | 0.240 |
Why?
|
| Age Factors | 2 | 2018 | 1187 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 297 | 0.210 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 24 | 0.200 |
Why?
|
| Thorax | 1 | 2022 | 29 | 0.200 |
Why?
|
| Troponin I | 1 | 2020 | 22 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2017 | 37 | 0.170 |
Why?
|
| Adolescent | 4 | 2020 | 3568 | 0.170 |
Why?
|
| Rural Population | 1 | 2021 | 277 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 169 | 0.170 |
Why?
|
| Sex Factors | 1 | 2020 | 667 | 0.160 |
Why?
|
| Ohio | 1 | 2018 | 58 | 0.150 |
Why?
|
| Interviews as Topic | 1 | 2018 | 266 | 0.150 |
Why?
|
| Cost Savings | 1 | 2016 | 33 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 62 | 0.140 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 99 | 0.140 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1165 | 0.130 |
Why?
|
| Hospitals | 1 | 2016 | 102 | 0.130 |
Why?
|
| Young Adult | 3 | 2020 | 2665 | 0.130 |
Why?
|
| Disease Management | 1 | 2016 | 126 | 0.130 |
Why?
|
| Risk | 1 | 2016 | 321 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2016 | 142 | 0.130 |
Why?
|
| Cardiology | 1 | 2016 | 99 | 0.130 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 27 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 510 | 0.120 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 18 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 2013 | 22 | 0.110 |
Why?
|
| African Americans | 1 | 2020 | 1424 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 62 | 0.110 |
Why?
|
| Positive-Pressure Respiration | 2 | 2003 | 9 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 3990 | 0.100 |
Why?
|
| Coronary Care Units | 1 | 2011 | 4 | 0.100 |
Why?
|
| Registries | 1 | 2013 | 298 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 240 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 462 | 0.100 |
Why?
|
| Knowledge | 1 | 2011 | 14 | 0.100 |
Why?
|
| Louisiana | 1 | 2011 | 11 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 149 | 0.100 |
Why?
|
| Hospitals, Urban | 1 | 2011 | 14 | 0.100 |
Why?
|
| Hospitals, University | 1 | 2011 | 30 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2011 | 65 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 129 | 0.090 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2010 | 2 | 0.090 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 4 | 0.090 |
Why?
|
| Acid-Base Equilibrium | 1 | 2010 | 10 | 0.090 |
Why?
|
| Bicarbonates | 1 | 2010 | 11 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 74 | 0.090 |
Why?
|
| Solutions | 1 | 2010 | 36 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2010 | 22 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1325 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 43 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 525 | 0.080 |
Why?
|
| Infant Equipment | 1 | 2008 | 1 | 0.080 |
Why?
|
| Job Application | 1 | 2008 | 6 | 0.080 |
Why?
|
| Ethanol | 1 | 2010 | 189 | 0.080 |
Why?
|
| Foreskin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Data Collection | 1 | 2008 | 181 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 566 | 0.070 |
Why?
|
| Drainage | 1 | 2007 | 72 | 0.070 |
Why?
|
| African Continental Ancestry Group | 1 | 2008 | 363 | 0.070 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 11 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 53 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 895 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 59 | 0.050 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2003 | 52 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2003 | 1020 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3304 | 0.050 |
Why?
|
| Liquid Ventilation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2002 | 6 | 0.050 |
Why?
|
| Child | 1 | 2008 | 2439 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2002 | 57 | 0.050 |
Why?
|
| Lung | 1 | 2002 | 249 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 1999 | 21 | 0.040 |
Why?
|
| Respiration | 1 | 1999 | 27 | 0.040 |
Why?
|
| Wakefulness | 1 | 1999 | 25 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 98 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 71 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 349 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2016 | 43 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 157 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2014 | 146 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 184 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 163 | 0.030 |
Why?
|
| Animals | 4 | 2010 | 7510 | 0.030 |
Why?
|
| Physical Examination | 1 | 2013 | 92 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 25 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 126 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 374 | 0.020 |
Why?
|
| Women's Health | 1 | 2013 | 235 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 753 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2010 | 8 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 158 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 71 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 185 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 123 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 181 | 0.020 |
Why?
|
| Cytokines | 1 | 2010 | 256 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 244 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 827 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 764 | 0.020 |
Why?
|
| Mice | 1 | 2010 | 2474 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 7 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 31 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 227 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 233 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 742 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 1999 | 2 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1999 | 4 | 0.010 |
Why?
|
| Rats | 1 | 2003 | 1592 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1999 | 62 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1999 | 28 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 197 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1999 | 203 | 0.010 |
Why?
|